Guardant Health
GH
#1787
Rank
โ‚น1.046 T
Marketcap
โ‚น7,980
Share price
-3.96%
Change (1 day)
106.24%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of December 2025 : โ‚น161.28 Billion

According to Guardant Health 's latest financial reports the company's total debt is โ‚น161.28 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2025)

Total debt by year

Year Total debt Change
2025-12-31โ‚น153.51 B33.94%
2024-12-31โ‚น114.61 B1.7%
2023-12-31โ‚น112.69 B-0.54%
2022-12-31โ‚น113.30 B10.82%
2021-12-31โ‚น102.24 B63.62%
2020-12-31โ‚น62.49 B2069.36%
2019-12-31โ‚น2.88 B
2018-12-31N/A-100%
2017-12-31โ‚น42.07 M-96.37%
2016-12-31โ‚น1.15 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Neogen
NEOG
โ‚น74.78 B-53.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
โ‚น20.21 B-87.46%๐Ÿ‡บ๐Ÿ‡ธ USA